RxSight Inc (RXST)
61.68
+2.05
(+3.44%)
USD |
NASDAQ |
May 03, 16:00
61.78
+0.10
(+0.15%)
After-Hours: 20:00
RxSight Cash from Operations (TTM): -41.59M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -41.59M |
| September 30, 2023 | -47.15M |
| June 30, 2023 | -54.35M |
| March 31, 2023 | -61.63M |
| December 31, 2022 | -58.85M |
| September 30, 2022 | -53.72M |
| June 30, 2022 | -52.28M |
| Date | Value |
|---|---|
| March 31, 2022 | -49.44M |
| December 31, 2021 | -44.71M |
| September 30, 2021 | -44.21M |
| June 30, 2021 | -37.41M |
| March 31, 2021 | -33.24M |
| December 31, 2020 | -35.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-61.63M
Minimum
Mar 2023
-33.24M
Maximum
Mar 2021
-47.21M
Average
-47.15M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
| Abbott Laboratories | 7.261B |
| Alphatec Holdings Inc | -78.48M |
| AtriCure Inc | -12.45M |
| Intuitive Surgical Inc | 1.708B |
| iRhythm Technologies Inc | -50.10M |